GlobalData on MSN
AtriCure treats first subject in BoxX-NoAF study
The procedure was carried out by Orlando Health Heart and Vascular Institute cardiothoracic surgeon Dr Anthony Rongione.
AtriCure (Nasdaq:ATRC) announced the first patient enrolled in its BoxX-NoAF clinical trial evaluating its cardiac therapy technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback